Related Experiment Videos

Work as a physician and adverse pregnancy outcomes: a Finnish nationwide population-based registry study

Reginald Quansah1, Mika Gissler, Jouni J K Jaakkola

  • 1Institute of Occupational and Environmental Medicine, University of Birmingham, Birmingham, UK.

Work as a physician may be related to several occupational hazards. Only few studies have investigated the relations between work as a physician and the risk of adverse pregnancy outcomes and the results have been inconsistent. We conducted a nationwide population-based study in Finland to assess whether work as a physician during pregnancy increases the risk of adverse pregnancy outcomes. We identified from the 1990 to 2006 Finnish Medical Birth Register data all singleton newborns of physicians (N = 7,642) and other upper white collar workers (N = 124,606; as the reference group) from a source population of 946,392 singleton newborns. In generalized estimating equations, work as a physician was not related to low birth weight (adjusted odds ratio (OR) 1.00, 95% confidence interval (CI 0.86-1.15), preterm delivery (1.00, 0.89-1.12), small-for-gestational age (1.04, 0.86-1.22), large-for-gestational age (1.00, 0.86-1.13), perinatal death (0.88, 0.49-1.27), and the female gender of the newborn (0.98, 0.94-1.03). The risk of high birth weight (4,000 g or more; 0.88, 0.84-0.93) and postterm delivery were lower (0.77, 0.65-0.89) among physicians than the reference group. The results indicate that Finnish female physicians have a similar risk of adverse pregnancy outcomes as women of similar socio-economic background.

Related Concept Videos

Introduction to Epidemiology01:26

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...